TECH ▼ -0.1% - Bio-Techne Corporation $TECH TECH - Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany Bio-Techne shareholders have approved the company's acquisition by Merck KGaA, a major German pharmaceutical and life sciences company. The modest 0.1% decline suggests the market had largely priced in the deal's approval following its announcement, with little new information moving the stock on the final shareholder vote. 23-SEP-2026 09:20 AM ET